Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02670057 · ClinicalTrials.gov registry record · NA

Sphenopalatine Ganglion Block to Treat Shoulder Pain During and/or After Cesarean

A NA study, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
117
Enrollment target

NCT02670057: Completed NA study, sponsored by NYU Langone Health.

NCT02670057 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 117 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02670057, a NA study, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
117 participants
Enrollment target

Study Summary

The purpose of this open label pilot study is to evaluate the utility of sphenopalatine ganglion (SPG) block to manage ipsilateral shoulder pain (ISP) during and/or after cesarean.

Interventions

  • PROCEDURE Transnasal SPG block

Trial Details

FieldValue
Enrollment Target 117 participants
Start Date 2015-11
Est. Completion 2017-12-12
Phase NA
NYU Langone Health

1,164 total trials

What the finished NCT02670057 record still lists

NCT02670057 is an interventional study that assigns participants to a tested intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 1 intervention - of which Transnasal SPG block is the first listed.

NCT02670057 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02670057 about?

NCT02670057 is a clinical study titled "Sphenopalatine Ganglion Block to Treat Shoulder Pain During and/or After Cesarean". The purpose of this open label pilot study is to evaluate the utility of sphenopalatine ganglion (SPG) block to manage ipsilateral shoulder pain (ISP) during and/or after cesarean.

What is the current status of trial NCT02670057?

This trial is currently completed. It is a NA study. The enrollment target is 117 participants. The study started on 2015-11. Estimated completion is 2017-12-12.

What interventions are being tested in trial NCT02670057?

The interventions under investigation include: Transnasal SPG block (PROCEDURE).

Who is sponsoring clinical trial NCT02670057?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02670057's enrollment target sits among peer trials

117 807th of 2000 higher than 1,193 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03539822 · 117 participants · Phase 1

    Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

  • NCT03786692 · 117 participants · Phase 2

    Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

  • NCT04479696 · 117 participants · NA

    Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors

  • NCT04940585 · 117 participants · NA

    ROSE in Sunset Park

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02670057, the US trial registry maintained by the National Library of Medicine. NCT02670057 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.